{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:12:58Z","timestamp":1784128378079,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115974"],"award-info":[{"award-number":["115974"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["241544"],"award-info":[{"award-number":["241544"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014915","name":"Juvenile Diabetes Research Foundation Netherlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.trsl.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T21:49:23Z","timestamp":1589147363000},"page":"17-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Baseline urinary metabolites predict albuminuria response to spironolactone in type 2 diabetes"],"prefix":"10.1016","volume":"222","author":[{"given":"Skander","family":"Mulder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Perco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Oxlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma F.","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ib A.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J.L.","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.04.010_bib0001","unstructured":"World Health Organization. Diabetes\u2014key facts. Available at: www.who.int. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes. 2018. Accessed June 21, 2019."},{"key":"10.1016\/j.trsl.2020.04.010_bib0002","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Global Kidney Disease 1 evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2020.04.010_bib0003","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 4","key":"10.1016\/j.trsl.2020.04.010_bib0004","doi-asserted-by":"crossref","first-page":"iv105","DOI":"10.1093\/ndt\/gfv210","article-title":"Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine","volume":"30","author":"Lambers Heerspink","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2020.04.010_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12882-016-0337-0","article-title":"Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis","volume":"17","author":"Currie","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0006","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","article-title":"Beneficial impact of spironolactone in diabetic nephropathy","volume":"68","author":"Schjoedt","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.04.010_bib0007","doi-asserted-by":"crossref","first-page":"iv17","DOI":"10.1093\/ndt\/gfv267","article-title":"Molecular disease presentation in diabetic nephropathy","volume":"30","author":"Heinzel","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2020.04.010_bib0008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/dc16-2202","article-title":"Systems biology-derived biomarkers to predict progression of renal function decline in type 2 diabetes","volume":"40","author":"Mayer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2020.04.010_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-0709-0_7","article-title":"Functional molecular units for guiding biomarker panel design","volume":"1159","author":"Heinzel","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"Database issue","key":"10.1016\/j.trsl.2020.04.010_bib0010","doi-asserted-by":"crossref","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","article-title":"DrugBank 3.0: a comprehensive resource for \u201comics\u201d research on drugs","volume":"39","author":"Knox","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2020.04.010_bib0011","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2217\/14622416.7.7.1025","article-title":"Toxicogenomics in drug discovery and development: mechanistic analysis of compound\/class-dependent effects using the DrugMatrix database","volume":"7","author":"Ganter","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.trsl.2020.04.010_bib0012","doi-asserted-by":"crossref","first-page":"073","DOI":"10.4172\/jcsb.1000102","article-title":"Using information content for expanding human protein coding gene interaction networks","volume":"6","author":"R","year":"2013","journal-title":"J Comput Sci Syst Biol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0013","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.trsl.2020.04.010_bib0014","doi-asserted-by":"crossref","first-page":"e13421","DOI":"10.1371\/journal.pone.0013421","article-title":"Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy","volume":"5","author":"Alkhalaf","year":"2010","journal-title":"PLoS One"},{"issue":"Database issue","key":"10.1016\/j.trsl.2020.04.010_bib0015","first-page":"D801","article-title":"HMDB 3.0\u2013The human metabolome database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2020.04.010_bib0016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/jhh.2014.27","article-title":"Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension","volume":"29","author":"Oxlund","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.trsl.2020.04.010_bib0017","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2288-14-75","article-title":"Tuning multiple imputation by predictive mean matching and local residual draws","volume":"14","author":"Morris","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00401706.1970.10488634","article-title":"Ridge regression: biased estimation for nonorthogonal problems","volume":"12","author":"Hoerl","year":"1970","journal-title":"Technometrics"},{"key":"10.1016\/j.trsl.2020.04.010_bib0020","series-title":"IJCAI'95: Proceedings of the 14th international joint conference on Artificial intelligence","first-page":"1137","article-title":"A study of cross-validation and bootstrap for accuracy estimation and model selection","author":"Kohavi","year":"1995"},{"key":"10.1016\/j.trsl.2020.04.010_bib0021","series-title":"The Elements of Statistical Learning: Data Mining, Inference, and Prediction","year":"2001"},{"issue":"3","key":"10.1016\/j.trsl.2020.04.010_bib0022","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/aje\/kwu140","article-title":"Correcting for optimistic prediction in small data sets","volume":"180","author":"Smith","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0023","doi-asserted-by":"crossref","first-page":"F1287","DOI":"10.1152\/ajprenal.00017.2008","article-title":"Aldosterone and TGF-\u03b2 1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells","volume":"294","author":"Huang","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0024","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-1797.2009.01181.x","article-title":"Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients","volume":"15","author":"Tiryaki","year":"2010","journal-title":"Nephrology (Carlton)"},{"issue":"s3","key":"10.1016\/j.trsl.2020.04.010_bib0025","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1440-1797.2007.00878.x","article-title":"Effects of therapeutic agents on the inflammatory and fibrogenic factors in IgA nephropathy","volume":"12","author":"IHM","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.trsl.2020.04.010_bib0026","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.0000174593.88899.68","article-title":"Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1\/2 in rat renal fibroblasts","volume":"46","author":"Nagai","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2020.04.010_bib0027","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1536\/ihj.48.637","article-title":"Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1)","volume":"48","author":"Takahashi","year":"2007","journal-title":"Int Heart J"},{"key":"10.1016\/j.trsl.2020.04.010_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000242477","article-title":"Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes","volume":"30","author":"Seo","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0029","doi-asserted-by":"crossref","first-page":"F639","DOI":"10.1152\/ajprenal.00189.2001","article-title":"Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation","volume":"282","author":"Zheng","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2002.00430.x","article-title":"Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies","volume":"62","author":"Rastaldi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.04.010_bib0031","article-title":"Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension","volume":"33","author":"Lindhardt","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2020.04.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010310","article-title":"Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial","volume":"6","author":"Lindhardt","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.trsl.2020.04.010_bib0033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00125-010-1923-5","article-title":"The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreatic beta cells","volume":"54","author":"Huypens","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2020.04.010_bib0034","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.trsl.2020.04.010_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"14","author":"Forbes","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2020.04.010_bib0036","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12967-016-0960-3","article-title":"Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus","volume":"14","author":"Pena","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.trsl.2020.04.010_bib0037","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12882-017-0767-3","article-title":"Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate","volume":"18","author":"Leong","year":"2017","journal-title":"BMC Nephrol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420300736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420300736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:13:37Z","timestamp":1778832817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420300736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":37,"alternative-id":["S1931524420300736"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.04.010","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline urinary metabolites predict albuminuria response to spironolactone in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}